The mortality rate for cervix uteri malignant neoplasms in Germany shows a slight declining trend from 2024 to 2028, starting at 1.53 thousand female deaths in 2024 and decreasing to 1.51 thousand by 2028. This reflects a gradual reduction, likely driven by improved medical interventions and increased screening efforts. Compared to 2023, the trend signifies a steady decrease that is expected to continue over the forecast period.
Year-on-year percentage variation reveals a relatively stable decline, suggesting consistent progress in healthcare measures. The Compound Annual Growth Rate (CAGR) illustrates a modest downward trend over the next five years.
Future trends to watch include the development and adoption of advanced diagnostic technologies, potential changes in healthcare policies, and the impact of awareness and prevention programs. Continued innovation and public health efforts will play a crucial role in further reducing mortality rates associated with cervix uteri malignant neoplasms.
